Curcumin compounds may be used to develop new anticancer drugs

Recently, the research team of Professor Hideki Hasegawa and Professor Yasuki Kanai of Kyoto University and therabiopharma Co., Ltd have successfully developed curcumin compounds with anticancer activity The research results have been published in the electronic edition of the journal Biological and pharmaceutical bulletin Professor hang Gu and others also plan to develop it into a new anticancer drug (http:// Curcumin contained in curcumin has the functions of anti acid, anti-inflammatory and anti-cancer However, curcumin is difficult to be absorbed by intestinal tract and is mostly discharged from the body In this regard, Professor Hangu's research team and theravalues Co., Ltd jointly developed the micro powder and granule curcumin The absorption rate of this product (http:// has been increased by 27 times, and the improvement effect on liver function has also been confirmed However, when taken orally, the concentration of the effective ingredients with anticancer effect in the blood has not been fully increased Based on the above research, the research team developed a new curcumin product, and gave the test mice of colon cancer transplantation intravenous injection test The results showed that the concentration of active ingredients in the blood increased about 1000 times, and the anti-cancer effect was also confirmed, while the test mice did not have side effects such as weight loss Professor hang Gu said that it is expected to develop into an anti-cancer drug with fewer side effects Moreover, from the perspective of animal experiments, it is also beneficial to the effects of lifestyle diseases and inflammatory diseases, and may also be used for the treatment of diseases other than cancer.